A new study suggests a recently approved drug for advanced pancreatic cancer may also be effective against lung cancer. This breakthrough drug has shown promise in treating pancreatic cancer and researchers are now exploring its potential in treating another type of cancer.

Further details about the study are available, but it appears the drug may have applications beyond its initial approval. The study's findings indicate that the drug could be used to treat lung cancer, in addition to pancreatic cancer.

More information about the study and its results can be found through the source, which provides additional details about the potential of this breakthrough drug.